Spexis AG (XSWX:SPEX) Total Assets : CHF16.78 Mil (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Spexis AG Total Assets?

Spexis AG's Total Assets for the quarter that ended in Dec. 2023 was CHF16.78 Mil.

During the past 12 months, Spexis AG's average Total Assets Growth Rate was -42.20% per year. During the past 3 years, the average Total Assets Growth Rate was 452.20% per year. During the past 5 years, the average Total Assets Growth Rate was 34.70% per year. During the past 10 years, the average Total Assets Growth Rate was -10.70% per year.

During the past 11 years, Spexis AG's highest 3-Year average Total Assets Growth Rate was 452.20%. The lowest was -81.60%. And the median was -6.05%.

Total Assets is connected with ROA %. Spexis AG's annualized ROA % for the quarter that ended in Dec. 2023 was -135.30%. Total Assets is also linked to Revenue through Asset Turnover. Spexis AG's Asset Turnover for the quarter that ended in Dec. 2023 was 0.00.

Spexis AG Total Assets Historical Data

The historical data trend for Spexis AG's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spexis AG Total Assets Chart

Spexis AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

92.77

0.34

49.97

29.95

16.78

Spexis AG Semi-Annual Data
	Dec13	Dec14	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Assets	Get a 7-Day Free Trial													49.97	40.00	29.95	29.67	16.78

Spexis AG Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Spexis AG's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	2.288	+	14.49
	=	16.78

Spexis AG's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	2.288	+	14.49
	=	16.78

Spexis AG (XSWX:SPEX) Total Assets Explanation

Total Assets is connected with ROA %.

Spexis AG's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	-31.42	/	( (29.667	+	16.778)	/ 2 )
	=	-31.42	/	23.2225
	=	-135.30 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Spexis AG's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	0	/	( (29.667	+	16.778)	/ 2 )
=	0	/	23.2225
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Spexis AG Total Assets Related Terms

Thank you for viewing the detailed overview of Spexis AG's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Spexis AG (XSWX:SPEX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Spexis AG (XSWX:SPEX) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

SPEXz:UK

Address

Hegenheimermattweg 125, Allschwil, CHE, CH-4123

Website

https://www.polyphor.com

Spexis AG is a clinical-stage biopharmaceutical company. The company is engaged in the discovery and development of antibiotics and other specialty pharma products for severe or life-threatening diseases. The company's lead product, murepavadin, is in Phase III development against Pseudomonas aeruginosa - recognized as a critical priority 1 pathogen by World Health Organization. It has one operating segment focusing on the research and development and prospective commercialization of respiratory therapeutics addressing high unmet medical needs.

Spexis AG (XSWX:SPEX) Headlines

No Headlines